Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· HRH.R. 6136 (116th)referred
United States · United States Congress · 9 March 2020
Protecting Consumers from Unreasonable Rates Act of 2020 This bill requires the Department of Health and Human Services (HHS) or the relevant state agency to ensure that any excessive, unjustified, or unfairly discriminatory premium rates for health care coverage are corrected before, or as soon as possible after, implementation, including through mechanisms such as denying rates, modifying rates, or requiring rebates to consumers. HHS may apply civil monetary penalties to health insurers that fail to comply with a corrective action taken by HHS and may decertify the plan as a qualified health plan. (Qualified health plans are sold on health insurance exchanges, the only plans eligible for premium subsidies, and meet the requirements for minimum essential coverage.) HHS must determine whether HHS or the state will undertake the corrective actions based on whether the state can adequately undertake the actions. The bill declares that the review by HHS of unreasonable increases in premiums does not prohibit a state from imposing on health insurers additional rate requirements that are more protective of consumers. The HHS review, which currently covers only premium increases, is expanded to include all rate increases.
Bill· HRH.R. 6149 (116th)referred
United States · United States Congress · 9 March 2020
Medicaid Report on Expansion of Access to Coverage for Health Act or Medicaid REACH Act This bill reduces federal payment for Medicaid administrative expenses incurred by states that have not elected to participate in Medicaid expansion under the Patient Protection and Affordable Care Act (i.e., nonexpansion states) if the state does not comply with specified reporting requirements. The bill requires nonexpansion states to report, among other information, the number of uninsured individuals under the age of 65 and the estimated percentage of such individuals who would be eligible to receive coverage if the state expanded Medicaid.
Bill· HRH.R. 6155 (116th)referred
United States · United States Congress · 9 March 2020
This bill requires the Food and Drug Administration (FDA) to continue to review applications for certain biological products under an earlier review process, notwithstanding recent FDA guidance. Specifically, the bill applies to applications that were filed under the earlier process on or before March 23, 2019, and were still pending on March 23, 2020. (A 2009 law established a new procedure for approving biological products but allowed certain products in an already approved product class to receive approval under the earlier procedure until March 23, 2020; subsequently, in December 2018, the FDA issued guidance stating that an application filed under the earlier procedure that is not approved by March, 23, 2020, will not be approved.)
Bill· HRH.R. 6150 (116th)referred
United States · United States Congress · 9 March 2020
Paid Sick Days for Public Health Emergencies and Personal and Family Care Act This bill expands the availability of paid sick time by requiring employers with at least one employee to provide a minimum amount of accrued paid sick time per work week and additional paid sick time in the event of a public-health emergency such as the coronavirus (i.e., the virus that causes COVID-19). Specifically, the bill requires employers to grant at least 1 hour of accrued paid sick time to each employee for every 30 hours worked, up to a minimum of 56 hours, or 7 days, of paid sick time per year. Accrued paid sick time may be used for, among other reasons, an absence from work that is taken (1) due to a medical condition or illness or for the diagnosis, care, or prevention thereof; (2) to care for a child, spouse, domestic partner, parent, or other close relative with a medical condition or illness, or for the diagnosis or prevention thereof; (3) during a public-health emergency when the employee's workplace has been closed or the employee has been exposed to a communicable disease and may pose a risk to others; or (4) to care for a child or close relative during such public-health emergency, if such relative has been exposed to a communicable disease or the child's school has been closed. Further, employees are immediately entitled to up to 14 days of additional paid sick time if a public-health emergency is declared. This additional paid sick time may be used during the public-health emergency for the same purposes as accrued paid sick time.
Bill· HRH.R. 6148 (116th)referred
United States · United States Congress · 9 March 2020
TRICARE ECHO Improvement Act This bill expands benefits available under the TRICARE Extended Health Care Option program for beneficiaries with special needs, including by expanding coverage of respite care and durable medical equipment.
Bill· HRH.R. 6130 (116th)referred
United States · United States Congress · 9 March 2020
Improving Awareness of Health Coverage Options Act This bill requires the Department of Labor to revise and publish on its website notice about the availability of Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA) continuation of health insurance coverage for employees losing job-based coverage. Such notice must explain specified enrollment information with respect to such coverage, such as (1) eligibility for financial assistance, (2) the option to enroll in a qualified plan through a health insurance exchange, (3) minimum coverage requirements of such qualified health plans, and (4) limitations on enrollment in a qualified health plan after terminating COBRA coverage.
Bill· HRH.R. 6159 (116th)referred
United States · United States Congress · 9 March 2020
Kids' Access to Primary Care Act of 2020 This bill applies a Medicare payment rate floor to Medicaid primary care services that are provided after the date of enactment of the bill, extends the payment rate to additional types of practitioners (e.g., obstetricians), and establishes other requirements with respect to payment for such services.
Bill· HRH.R. 6151 (116th)referred
United States · United States Congress · 9 March 2020
Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act or the CARING for Kids Act This bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
Bill· HRH.R. 6147 (116th)referred
United States · United States Congress · 9 March 2020
Help Extend Auditory Relief (HEAR) Act of 2020 This bill provides for Medicare coverage of hearing aids and hearing rehabilitation services, in accordance with specified criteria and limitations.
Bill· HRH.R. 6144 (116th)referred
United States · United States Congress · 9 March 2020
Kira Johnson Act This bill directs the Department of Health and Human Services (HHS) to award grants to improve outcomes and reduce bias, racism, and discrimination in maternal care settings. Specifically, HHS must award grants to (1) community-based programs to improve maternal health outcomes for African American women, (2) eligible entities to provide certain training to health care providers and others who work in maternity care settings, and (3) specified health care facilities to establish respectful maternity care compliance offices. The National Academies of Sciences, Engineering, and Medicine must study issues related to the training programs, and the Government Accountability Office must study the implementation and impact of the compliance offices.
Bill· HRH.R. 6138 (116th)referred
United States · United States Congress · 9 March 2020
Tech to Save Moms Act This bill supports the use of technology to address maternal health outcomes. Specifically, the bill permits the Center for Medicare and Medicaid Innovation to test telehealth models to screen and treat common pregnancy-related complications for Medicaid enrollees and establishes two grant programs that leverage technology to address maternal health outcomes. The Department of Health and Human Services must award grants to (1) entities that provide services to pregnant and postpartum women in specified areas, or from certain populations, to evaluate and expand technology-enabled collaborative learning models; and (2) public or private entities, including tribes, to reduce racial and ethnic disparities in maternal health outcomes by increasing access to digital tools. In addition, the National Academies of Sciences, Engineering, and Medicine must study the use of technology to reduce preventable maternal mortality and severe maternal morbidity and racial and ethnic disparities in maternal health outcomes.
Bill· HRH.R. 6137 (116th)referred
United States · United States Congress · 9 March 2020
Innovative Maternal Payment And Coverage To Save Moms Act or the IMPACT to Save Moms Act of 2020 This bill requires the Centers for Medicare & Medicaid Services to establish the Perinatal Care Alternative Payment Model Demonstration Project to allow states to test payment models for maternity care, including postpartum care, under Medicaid and the Children's Health Insurance Program (CHIP). Additionally, the Medicaid and CHIP Payment and Access Commission must report on specified information relating to the continuity of coverage for pregnant and postpartum women under Medicaid and CHIP.
Bill· HRH.R. 6129 (116th)referred
United States · United States Congress · 9 March 2020
Justice for Incarcerated Moms Act This bill directs specified activities to address maternal health outcomes among incarcerated individuals. Specifically, the bill reduces certain federal funding for criminal justice activities to states without laws restricting the use of restraints on pregnant women who are incarcerated: establishes programs in federal Bureau of Prisons facilities, and a grant program to be administered by the Bureau of Justice Assistance for state and local correctional facilities, to improve maternal health outcomes; and requires reports from the Government Accountability Office and the Medicaid and CHIP Payment and Access Commission on specified topics related to pregnant and postpartum women who are incarcerated.
Bill· HRH.R. 6143 (116th)referred
United States · United States Congress · 9 March 2020
Moms Maternal and Behavioral Health Screening Access, Treatment, and Task Force to Expand Innovative Models to Reduce Maternal Mortality and Severe Maternal Morbidity Act of 2020 or the Moms MATTER Act of 2020 This bill establishes the Maternal Mental and Behavioral Health Task Force and directs the Department of Health and Human Services to award grants to eligible health care entities to support innovative models of maternity care, including group prenatal and postnatal care models, designed to reduce racial and ethnic disparities in health outcomes.
Resolution· HRESH.Res. 888 (116th)referred
United States · United States Congress · 9 March 2020
This resolution expresses support for the goals and ideas of Endometriosis Awareness Month. (Endometriosis is a painful condition in which the tissue that normally lines the inside of the uterus grows outside the uterus.) It also recognizes the need for early detection and treatment of endometriosis, increased education for health care providers, and more culturally competent care.
Bill· HRH.R. 6092 (116th)referred
United States · United States Congress · 5 March 2020
Veteran's Prostate Cancer Treatment and Research Act This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer. Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment. The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually. Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation. Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.
Bill· HRH.R. 6099 (116th)referred
United States · United States Congress · 5 March 2020
Equal Treatment of Faith-Based Organizations Act of 2020 This bill provides statutory authority for certain restrictions on conditions for financial assistance and program participation imposed by the Department of Health and Human Services (HHS) with respect to faith-based organizations. Specifically, HHS shall not impose specified conditions on faith-based organizations regarding the receipt of HHS funds or the participation in HHS programs, such as requirements to disclose religious affiliation, if those conditions are not imposed on organizations that are not faith-based. In addition, HHS shall not require any organization to refer a beneficiary who objects to the religious character of that organization to an alternative provider. States and local governments that administer HHS funds must adhere to these requirements, as well. Under current law, these restrictions apply to HHS financial assistance and programs through an executive order concerning the administration of federal grants and programs related to faith-based organizations.
Bill· HRH.R. 6098 (116th)referred
United States · United States Congress · 5 March 2020
This bill allows states to cover, under the Children's Health Insurance Program (CHIP), children whose family income exceeds the otherwise applicable income eligibility standards.
Bill· HRH.R. 6113 (116th)referred
United States · United States Congress · 5 March 2020
ARPA-H20 Act of 2020 This bill establishes the Advanced Research Projects Agency–Water within the Environmental Protection Agency to provide funding for projects concerning the treatment of drinking water or wastewater at water systems that serve the public. The water systems must be large decentralized systems that provide treatment for at least two households. The projects must be intended to enhance, through the deployment of advanced technologies, the treatment, monitoring, delivery, affordability, and safety of drinking water provided by a water system, wastewater or stormwater discharged by a water system, groundwater or well water used for drinking water, or activities carried out by a water system for the purposes of enhancing public health or environmental safety.
Bill· HRH.R. 6102 (116th)referred
United States · United States Congress · 5 March 2020
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020 This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
Bill· SS. 3404 (116th)referred
United States · United States Congress · 5 March 2020
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020 This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
Bill· SS. 3399 (116th)referred
United States · United States Congress · 5 March 2020
Frontier Community Health Integration Project Extension Act or the FCHIP Extension Act This bill reauthorizes the Frontier Community Health Integration Project (FCHIP) through August 1, 2024. (FCHIP is a demonstration project that aims to improve access to, and integration of, acute care, extended care, and other health services for Medicare beneficiaries in rural areas.)
Bill· SS. 3415 (116th)referred
United States · United States Congress · 5 March 2020
Paid Sick Days for Public Health Emergencies and Personal and Family Care Act This bill expands the availability of paid sick time by requiring employers with at least one employee to provide a minimum amount of accrued paid sick time per work week and additional paid sick time in the event of a public-health emergency such as the coronavirus (i.e., the virus that causes COVID-19). Specifically, the bill requires employers to grant at least 1 hour of accrued paid sick time to each employee for every 30 hours worked, up to a minimum of 56 hours, or 7 days, of paid sick time per year. Accrued paid sick time may be used for, among other reasons, an absence from work that is taken (1) due to a medical condition or illness or for the diagnosis, care, or prevention thereof; (2) to care for a child, spouse, domestic partner, parent, or other close relative with a medical condition or illness, or for the diagnosis or prevention thereof; (3) during a public-health emergency when the employee's workplace has been closed or the employee has been exposed to a communicable disease and may pose a risk to others; or (4) to care for a child or close relative during such public-health emergency, if such relative has been exposed to a communicable disease or the child's school has been closed. Further, employees are immediately entitled to up to 14 days of additional paid sick time if a public-health emergency is declared. This additional paid sick time may be used during the public-health emergency for the same purposes as accrued paid sick time.
Law· HRH.R. 6074 (116th)enacted
United States · United States Congress · 4 March 2020
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 This bill provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak. Within the Department of Health and Human Services (HHS), the bill provides FY2020 supplemental appropriations for the Food and Drug Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Public Health and Social Services Emergency Fund. In addition, the bill provides supplemental appropriations for the Small Business Administration, the Department of State, and the U.S. Agency for International Development. The supplemental appropriations are designated as emergency spending, which is exempt from discretionary spending limits. The programs funded by the bill address issues such as developing, manufacturing, and procuring vaccines and other medical supplies; grants for state, local, and tribal public health agencies and organizations; loans for affected small businesses; evacuations and emergency preparedness activities at U.S. embassies and other State Department facilities; and humanitarian assistance and support for health systems in the affected countries. The bill also allows HHS to temporarily waive certain Medicare restrictions and requirements regarding telehealth services during the coronavirus public health emergency.
Bill· HRH.R. 6077 (116th)referred
United States · United States Congress · 4 March 2020
Woman's Right To Know Act This bill specifies requirements for informed consent that health care providers must obtain before performing an abortion procedure. Providers must present a woman seeking an abortion with an authorization form at least 24 hours before performing the procedure. The form must (1) include specified information concerning gestational age, associated developmental characteristics, and medical risks; (2) disclose penalties that providers may face for failing to obtain the requisite informed consent; and (3) include an affirmation that the individual signing the form understands the information. The form must be signed and witnessed in person and retained in the medical file. Providers do not have to obtain such consent if, in reasonable medical judgment, obtaining it would pose a greater risk of death or substantial physical impairment of a major bodily function, excluding psychological or emotional conditions, of the pregnant woman. The bill also establishes civil penalties for providers who do not comply with these requirements.
Bill· HRH.R. 6090 (116th)referred
United States · United States Congress · 4 March 2020
Physician Shortage GME Cap Flex Act of 2020 This bill excludes certain hospitals that establish shortage specialty programs from the cap on full-time equivalent residents that is otherwise applicable, and provides for a new building period, for purposes of graduate medical education payments under Medicare.
Bill· HRH.R. 6080 (116th)referred
United States · United States Congress · 4 March 2020
Preventing Drug Shortages Act This bill expands existing manufacturer reporting requirements related to shortages of life-saving drugs and contains other related provisions. The bill requires a manufacturer of an active pharmaceutical ingredient of a life-saving drug to notify the Food and Drug Administration (FDA) of an interruption that is likely to lead to a meaningful disruption in the ingredient's supply, whereas under current law this requirement generally applies only to the manufacturer of a life-saving drug that faces a supply disruption. The notification must contain specified information, including any alternative sources for the ingredient. The bill also requires a manufacturer of a life-saving drug or an active pharmaceutical ingredient for such a drug to include in its annual product registration the specific facilities where the drug or ingredient is manufactured. The FDA may also require the manufacturer to conduct periodic risk assessments to address vulnerabilities in its supply chain. The Government Accountability Office shall report to Congress on the FDA's intra-agency coordination in assessing drug shortage risks.
Resolution· HRESH.Res. 885 (116th)referred
United States · United States Congress · 4 March 2020
This resolution supports the designation of National Assistive Technology Awareness Day. It also commends assistive technology specialists, program coordinators, organizations, and researchers for their assistance in helping people with disabilities to access such technology.
Resolution· SRESS.Res. 530 (116th)passed
United States · United States Congress · 4 March 2020
This resolution supports the designation of National Assistive Technology Awareness Day. It also commends assistive technology specialists, program coordinators, organizations, and researchers for their assistance in helping people with disabilities to access such technology.
Bill· SS. 3385 (116th)referred
United States · United States Congress · 4 March 2020
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2020 or the BENEFIT Act of 2020 This bill requires the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs. After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.
Bill· SS. 3388 (116th)referred
United States · United States Congress · 4 March 2020
Woman's Right To Know Act This bill specifies requirements for informed consent that health care providers must obtain before performing an abortion procedure. Providers must present a woman seeking an abortion with an authorization form at least 24 hours before performing the procedure. The form must (1) include specified information concerning gestational age, associated developmental characteristics, and medical risks; (2) disclose penalties that providers may face for failing to obtain the requisite informed consent; and (3) include an affirmation that the individual signing the form understands the information. The form must be signed and witnessed in person and retained in the medical file. Providers do not have to obtain such consent if, in reasonable medical judgment, obtaining it would pose a greater risk of death or substantial physical impairment of a major bodily function, excluding psychological or emotional conditions, of the pregnant woman. The bill also establishes civil penalties for providers who do not comply with these requirements.
Bill· SS. 3390 (116th)referred
United States · United States Congress · 4 March 2020
Physician Shortage GME Cap Flex Act of 2020 This bill excludes certain hospitals that establish shortage specialty programs from the cap on full-time equivalent residents that is otherwise applicable, and provides for a new building period, for purposes of graduate medical education payments under Medicare.
Resolution· SRESS.Res. 529 (116th)passed
United States · United States Congress · 4 March 2020
This resolution designates February 29, 2020, as Rare Disease Day. The resolution also recognizes the importance of improving awareness, encouraging accurate and early diagnosis, and supporting national and global efforts to develop effective treatments, diagnostics, and cures.
Bill· HRH.R. 6062 (116th)open
United States · United States Congress · 3 March 2020
This bill expands existing requirements relating to supply shortages of life-saving drugs to also apply to life-saving medical devices. Generally, a manufacturer must (1) notify the Food and Drug Administration (FDA) of supply interruptions in certain circumstances, (2) provide for the expedited review of a new device that may mitigate the shortage, and (3) allow the FDA to authorize the importation of the device for emergency medical care.
Resolution· HRESH.Res. 883 (116th)referred
United States · United States Congress · 3 March 2020
This resolution expresses support for the designation of National Triple-Negative Breast Cancer Day. (Triple-negative breast cancer is a distinct form of cancer that does not have the hormone and protein receptors commonly found in breast cancer.)
Bill· HRH.R. 6068 (116th)referred
United States · United States Congress · 3 March 2020
This bill requires the Department of Health and Human Services (HHS) to study health outcomes related to the use of e-cigarettes during pregnancy. HHS must also address the harmful effects of tobacco use on pregnancy in its youth-focused tobacco-prevention campaigns.
Bill· HRH.R. 6070 (116th)referred
United States · United States Congress · 3 March 2020
Border Health Security Act of 2020 This bill modifies the duties and activities of the United States-Mexico Border Health Commission and the Canada-United States Pan-Border Public Health Preparedness Council, and makes other changes to address health issues along the U.S. border. Specifically, the commission must cooperate with the council where appropriate, and members of the commission may provide advice or recommendations to the Department of Health and Human Services (HHS) or Congress without authorization or a request. Both the commission and the council must develop strategic plans, work plans, evaluations, and reports concerning their activities. HHS must award grants to (1) eligible entities in border areas to address recommendations of the commission and the council to improve the health of border area residents; and (2) trauma centers, public health entities, and state, local, or tribal entities for infectious disease surveillance activities in border areas. In addition, the Office of the Assistant Secretary for Preparedness and Response may coordinate with the Department of Homeland Security in establishing a system that alerts clinicians and public health officials to emerging health threats in border areas. The Government Accountability Office must evaluate commission and council activities every two years.
Bill· SS. 3384 (116th)referred
United States · United States Congress · 3 March 2020
Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.
Bill· SS. 3383 (116th)referred
United States · United States Congress · 3 March 2020
Continuing Coverage for Preexisting Conditions Act of 2020 This bill establishes severability between provisions relating to the requirement to maintain minimum essential health care coverage (i.e., the individual mandate) and other provisions of the Patient Protection and Affordable Care Act. Specifically, the bill provides that if the individual mandate is found to be illegal or incapable of being enforced, such findings do not affect the validity of other provisions relating to (1) the availability and renewability of coverage, or (2) the prohibitions against discriminatory coverage practices based on preexisting conditions or health status.
Bill· SS. 3380 (116th)referred
United States · United States Congress · 3 March 2020
Patient Safety Improvement Act of 2020 This bill directs the Department of Health and Human Services (HHS) to undertake actions related to (1) health care-associated infections (HAI), (2) antimicrobial stewardship, and (3) patient safety. With respect to HAI, HHS must award grants for state and regional infection control programs and must establish a pilot program related to HAI data reporting by long-term care facilities and others. HHS must also award grants to eligible entities for infection control during patient care transitions, and the Centers for Medicare & Medicaid Services (CMS) must develop guidance regarding transfers or discharges of patients with HAI diagnoses. The Government Accountability Office must evaluate the adequacy of oversight and validation of specified HAI data reporting. With respect to antimicrobial stewardship, the Centers for Disease Control and Prevention must award grants to states to implement antimicrobial stewardship plans and must otherwise take steps to address antibiotic prescribing. With respect to patient safety, the HHS must incentivize state medical boards to require education on patient safety topics as a condition of licensure, and the CMS must harmonize quality measure reporting requirements through a collaborative that includes representatives from, among other groups, insurers and patient groups. In addition, as a condition of a hospital's participation in Medicare, members of the hospital's board must periodically receive training on relevant patient safety topics.
Bill· SS. 3376 (116th)referred
United States · United States Congress · 3 March 2020
Pathways to Health Careers Act This bill extends, revises, and provides funds for certain demonstration grant programs to train low-income individuals for jobs considered part of the health care career pathway. The Department of Health and Human Services must provide targeted technical assistance to grantees and conduct an evaluation of the demonstration projects.
Bill· SS. 3374 (116th)referred
United States · United States Congress · 3 March 2020
Protecting Jessica Grubb's Legacy Act This bill more closely aligns the federal privacy standards applicable to substance-use disorder patient records with the relevant privacy and de-identification standards applicable to other records that contain personal health information for the purposes of (1) treatment, payment, and health care operations by health plans, providers, or clearinghouses; and (2) disclosures to public health authorities. The bill requires patients to give affirmative, written consent; once given, that consent applies to future disclosures. Such consent may be revoked by written request. The bill also (1) aligns criminal penalties for certain violations involving substance-use disorder patient records with the penalties that apply to violations involving other types of records containing personal health information; (2) expands the current prohibition against using substance-use disorder patient records in criminal proceedings to include any use in specified federal, state, and local criminal and civil actions; and (3) prohibits certain discrimination based on the release of such patient information with respect to access to treatment, employment, housing, and certain social services and benefits.
Resolution· HRESH.Res. 880 (116th)referred
United States · United States Congress · 2 March 2020
This resolution expresses support for the goals and ideals of National Colorectal Cancer Awareness Month.
Bill· HRH.R. 6049 (116th)referred
United States · United States Congress · 2 March 2020
Medical Supply Chain Security Act This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.
Bill· SS. 3370 (116th)referred
United States · United States Congress · 2 March 2020
Coronavirus Vaccine Act This bill directs the National Institute of Allergy and Infectious Diseases to conduct or support research to develop a coronavirus vaccine.
Bill· SS. 3372 (116th)referred
United States · United States Congress · 2 March 2020
Health Care Workforce Protection Act of 2020 This bill extends targeted liability protection to certain manufacturers, distributors, prescribers, and users of approved respiratory protective devices that are used under certain conditions during a declared public health emergency.
Bill· HRH.R. 6040 (116th)referred
United States · United States Congress · 28 February 2020
Small Business Relief From Communicable Disease Induced Economic Hardship Act of 2020 This bill expands the definition of a disaster for which the Small Business Administration (SBA) may provide disaster loans to small business concerns to include communicable diseases for which the government issues a travel alert or travel warning, and it authorizes the SBA to make interest free disaster loans to small businesses affected by a disaster for which the government issues a public health emergency.
Bill· HRH.R. 6019 (116th)referred
United States · United States Congress · 28 February 2020
Cure the Coronavirus Act This bill expands the tropical disease priority review voucher program to include COVID-19 (a respiratory disease caused by a novel coronavirus), thereby providing manufacturers with incentives for development of a vaccine.
Bill· SS. 3350 (116th)referred
United States · United States Congress · 27 February 2020
State Veterans Home Inspection Simplification Act This bill alters certain requirements relating to inspection and certification of Medicare skilled nursing facilities that are also state veterans homes. Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to treat state veterans homes that are inspected and determined to meet applicable standards set by the Department of Veterans Affairs (VA) as also meeting applicable standards for skilled nursing facilities under Medicare. The CMS must also use VA inspection reports for such facilities in lieu of state inspection reports for purposes of the Nursing Home Compare website.
Bill· HRH.R. 5997 (116th)referred
United States · United States Congress · 27 February 2020
Emergency Response Coordinator Act of 2020 This bill requires the Department of Health and Human Services to designate an official within the department to coordinate federal efforts with respect to COVID-19 (a respiratory disease caused by a novel coronavirus).
PreviousPage 25 of 26Next